Document Detail


Electrophysiological effects, efficacy and safety of intravenous propafenone in termination of atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia: a prospective non-randomized interventional study.
MedLine Citation:
PMID:  20635581     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of this prospective, non-randomized interventional study was to assess electrophysiological effects, efficacy and safety of intravenous propafenone in termination of atrioventricular nodal reentrant tachycardia (AVNRT) and orthodromic atrioventricular reentrant tachycardia (AVRT). This single-center study was carried out at Department of Cardiology, Sestre milosrdnice University Hospital in Zagreb, Croatia, between January 1, 2005 and December 31, 2006. Eligibility requirements were fulfilled by a total of 70 patients with AVNRT (n=37) and AVRT (n=33). The intervention consisted of the electrophysiological study aimed at inducing tachycardia, followed by intravenous administration of 2 mg/kg propafenone in both groups. The main outcome measures were safety and efficacy of 2 mg/kg intravenous propafenone in tachycardia termination and re-induction. Out of 37 patients with AVNRT, propafenone managed to terminate it in 28 (75.7%) patients, while tachycardia was not inducible in 25 (67.56%) patients. Out of 33 patients with AVRT, propafenone managed to terminate AVRT in 29 (87.9%) patients, while tachycardia was not inducible in 22 (66.66%) patients. The overall propafenone efficacy in tachycardia termination was 81.42%. No propafenone-related adverse effects were recorded during the study period. Propafenone was found to be a safe and effective anti-arrhythmic drug and can be justifiably administered for AVNRT and AVRT termination. It could be considered as an alternative to adenosine and verapamil.
Authors:
Hrvoje Pintarić; Sime Manola; Janko Szavits Nossan; Nikola Pavlović; Diana Delić-Brkljacić; Vjekoslav Radeljić
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Acta clinica Croatica     Volume:  49     ISSN:  0353-9466     ISO Abbreviation:  Acta Clin Croat     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-07-19     Completed Date:  2010-08-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9425483     Medline TA:  Acta Clin Croat     Country:  Croatia    
Other Details:
Languages:  eng     Pagination:  25-31     Citation Subset:  IM    
Affiliation:
Department of Cardiology, University Department of Medicine, Sestre milosrdnice University Hospital, Zagreb, Croatia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Anti-Arrhythmia Agents / administration & dosage*
Electrophysiologic Techniques, Cardiac
Female
Humans
Infusions, Intravenous
Injections, Intravenous
Male
Middle Aged
Propafenone / administration & dosage*
Tachycardia, Atrioventricular Nodal Reentry / drug therapy*,  physiopathology
Young Adult
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 54063-53-5/Propafenone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Daily hospice: Depression and anxiety after mastectomy for breast cancer.
Next Document:  Magnetic resonance imaging in the diagnosis of malignant tumors of the maxillofacial region.